SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-025470
Filing Date
2020-05-14
Accepted
2020-05-14 16:20:22
Documents
56
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q acer-10q_20200331.htm 10-Q 1361142
2 EX-31.1 acer-ex311_10.htm EX-31.1 17831
3 EX-31.2 acer-ex312_8.htm EX-31.2 17511
4 EX-32.1 acer-ex321_11.htm EX-32.1 7887
5 EX-32.2 acer-ex322_6.htm EX-32.2 7684
6 GRAPHIC gf2hltfeqokq000001.jpg GRAPHIC 1836
  Complete submission text file 0001564590-20-025470.txt   4321665

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT acer-20200331.xml EX-101.INS 664439
8 XBRL TAXONOMY EXTENSION SCHEMA acer-20200331.xsd EX-101.SCH 40655
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acer-20200331_cal.xml EX-101.CAL 32821
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acer-20200331_def.xml EX-101.DEF 126356
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE acer-20200331_lab.xml EX-101.LAB 350056
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acer-20200331_pre.xml EX-101.PRE 245568
Mailing Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 351 NEWTON MA 02458
Business Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 351 NEWTON MA 02458 (844) 902-6100
Acer Therapeutics Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 320426967 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33004 | Film No.: 20878077
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences